Covid-19: HC says not in agreement with Centre on availability of oxygen

The Delhi High Court said it was not in agreement with the Centre that there is enough oxygen available to treat seriously ill Covid-19 patients in the national capital

OXYGEN
Workers refill cylinders with medical oxygen for supply for Covid-19 patients, amid a surge in coronavirus cases. Photo: PTI
Press Trust of India New Delhi
2 min read Last Updated : Apr 26 2021 | 9:04 PM IST

The Delhi High Court Monday said it was not in agreement with the Centre that there is enough oxygen available to treat seriously ill COVID-19 patients in the national capital.

"Today there is shortage (of oxygen). The Solicitor Genersl says there is no shortage but we will not accept it because we have ourselves seen there is shortage of oxygen," said a bench of Justices Vipin Sanghi and Rekha Palli.

Solicitor General (SG) Tushar Mehta, representing the Centre, said his submission was that there is enough oxygen if distributed properly and the issue was of transportation and not the supply.

I have not said Delhi has enough oxygen. I am saying right now we have enough oxygen if distributed properly, he said.

During the hearing, petitioner advocate Rakesh Malhotra made the submission that there was shortage of RT-PCR kits.

Taking note of the submission, the bench said it has already directed the Centre to take steps to prioritise clearance of imported kits held up with the custom department.

The Centre's counsel apprised the court that necessary directions have already been issued by the government to the custom officers.

The court also directed the Centre to take steps to prioritise the clearance of customs for the import of RT-PCR testing kits from abroad.

It asked the Centre to file a report in sealed cover within three days on the number of imports pending and cleared and the reason for being held up.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus TestsHealth crisisOxygenDelhi High CourtDelhi

First Published: Apr 26 2021 | 9:00 PM IST

Next Story